Psoriatic Arthritis

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
Mark Kacar, John Fitton, Andrew K Gough, Maya H Buch, Dennis G McGonagle, Sinisa Savic

RMD Open Jul 2020, 6 (2) e001246; DOI: 10.1136/rmdopen-2020-001246
Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis
Hannah den Braanker, Kim Wervers, Adriana M C Mus, Priyanka S Bangoer, Nadine Davelaar, Jolanda Luime, Ilja Tchetverikov, J M W Hazes, Marijn Vis, Erik Lubberts, Marc R Kok

RMD Open Jul 2020, 6 (2) e001175; DOI: 10.1136/rmdopen-2020-001175
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study
Philip J Mease, Dafna D Gladman, Atul Deodhar, Dennis G McGonagle, Peter Nash, Wolf-Henning Boehncke, Alice Gottlieb, Xie L Xu, Stephen Xu, Elizabeth C Hsia, Chetan S Karyekar, Philip S Helliwell

RMD Open Jul 2020, 6 (2) e001217; DOI: 10.1136/rmdopen-2020-001217
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study
P G Conaghan, Rieke Alten, Atul Deodhar, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal Gandhi, Steffen M Jugl, Vibeke Strand

RMD Open Jun 2020, 6 (2) e001240; DOI: 10.1136/rmdopen-2020-001240
Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era
Glenn Haugeberg, Brigitte Michelsen, Arthur Kavanaugh

RMD Open May 2020, 6 (1) e001223; DOI: 10.1136/rmdopen-2020-001223
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices
Ennio Lubrano, Silvia Scriffignano, Ana Belen Azuaga, Julio Ramirez, Juan D Cañete, Fabio Massimo Perrotta

RMD Open Mar 2020, 6 (1) e001170; DOI: 10.1136/rmdopen-2020-001170
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis
Adeline Ruyssen-Witrand, Richard Perry, Clare Watkins, George Braileanu, Gayathri Kumar, Sandeep Kiri, Debby Nott, Soyi Liu-Leage, Susanne Hartz, Christophe Sapin

RMD Open Feb 2020, 6 (1) e001117; DOI: 10.1136/rmdopen-2019-001117
Treat-to-target in PsA: methods and necessity
Emma Dures, Sasha Shepperd, Sandeep Mukherjee, Jo Robson, Ivo Vlaev, Nicola Walsh, Laura C Coates

RMD Open Feb 2020, 6 (1) e001083; DOI: 10.1136/rmdopen-2019-001083
Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS)
Ashish J Mathew, Simon Krabbe, Iris Eshed, Robert GW Lambert, Jean-Denis Laredo, Walter P Maksymowych, Frederique Gandjbakhch, Yasser Emad, Maria Simona Stoenoiu, Violaine Foltz, Paul Bird, Philippe Carron, Joel Paschke, Philip G Conaghan, Susanne J Pedersen, Daniel Glinatsi, Mikkel Østergaard

RMD Open Feb 2020, 6 (1) e001150; DOI: 10.1136/rmdopen-2019-001150
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials
Philip S Helliwell, Dafna D Gladman, Soumya D Chakravarty, Shelly Kafka, Chetan S Karyekar, Yin You, Kim Campbell, Kristen Sweet, Arthur Kavanaugh, Lianne S Gensler

RMD Open Feb 2020, 6 (1) e001149; DOI: 10.1136/rmdopen-2019-001149

Main menu

Psoriatic Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriatic Arthritis

Pages